MedPath

Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children

Completed
Conditions
Primary Ciliary Dyskinesia
Cystic Fibrosis
Interventions
Other: Measurement of functional capacity
Other: pulmonary function test
Other: Functional capacity
Other: Peripheral muscle strength
Other: Respiratory muscle strength
Registration Number
NCT04161313
Lead Sponsor
Bezmialem Vakif University
Brief Summary

The aim of this study is to compare pulmonary function, respiratory muscle strength, exercise capacity and peripheral muscle strength of patients with CF, PCD and healthy childrens.

Detailed Description

The impaired airway clearence and pulmonary functions, exercise intolerance, low physical activity level and decreased peripheral muscle strength make physiotherapy approaches important in the management of CF and PCD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
  • Diagnosis of cystic fibrosis or primary ciliary dyskinesia
Exclusion Criteria
  • Hospitalization history in past month
  • Diagnosis of other chronic pediatric diseases which may impair exercise tolerance such as cerebral palsy or neuromuscular disease
  • Candidates for lung transplantation or history of lung transplantation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cystic fibrosisPeripheral muscle strengthchildren with cystic fibrosis
Cystic fibrosispulmonary function testchildren with cystic fibrosis
Cystic fibrosisFunctional capacitychildren with cystic fibrosis
healthy controlsRespiratory muscle strengthAge-matched healthy volunteers
primary ciliary dyskinesiapulmonary function testchildren with primary ciliary dyskinesia
Cystic fibrosisMeasurement of functional capacitychildren with cystic fibrosis
primary ciliary dyskinesiaMeasurement of functional capacitychildren with primary ciliary dyskinesia
healthy controlsMeasurement of functional capacityAge-matched healthy volunteers
healthy controlsFunctional capacityAge-matched healthy volunteers
primary ciliary dyskinesiaPeripheral muscle strengthchildren with primary ciliary dyskinesia
healthy controlspulmonary function testAge-matched healthy volunteers
healthy controlsPeripheral muscle strengthAge-matched healthy volunteers
Cystic fibrosisRespiratory muscle strengthchildren with cystic fibrosis
primary ciliary dyskinesiaFunctional capacitychildren with primary ciliary dyskinesia
primary ciliary dyskinesiaRespiratory muscle strengthchildren with primary ciliary dyskinesia
Primary Outcome Measures
NameTimeMethod
Six-minute walk test distance15 minutes

Distance walked in six minutes will be recorded in meters. Test will be conducted according to the guideline of American Thoracic Society (ATS).

Secondary Outcome Measures
NameTimeMethod
Forced Vital Capacity (FVC)5 minutes

FVC will be measured using basic spirometry and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)

Forced Expiratory Volume in 1 second (FEV1)5 minutes

FEV1 will be measured using basic spirometry and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)

Peak Expiratory Flow (PEF)5 minutes

PEF will be measured using basic spirometry and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)

M. Quadriceps strength5 minutes

Isometric M. Quadriceps strength (kg) will be measured using electronic hand held dynamometer in sitting position.

Trial Locations

Locations (1)

Bezmialem Vakıf University

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath